Insider Trading Alert - STRA, MMP And CLB Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Nov. 17, 2014, 106 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $573.98 to $39,999,000.00.

Highlighted Stocks Traded by Insiders:

Strayer Education (STRA) - FREE Research Report

Brown Mark C, who is EVP & Chief Financial Officer at Strayer Education, sold 7,000 shares at $78.23 on Nov. 17, 2014. Following this transaction, the EVP & Chief Financial Officer owned 34,472 shares meaning that the stake was reduced by 16.88% with the 7,000-share transaction.

The shares most recently traded at $76.97, down $1.26, or 1.64% since the insider transaction. Historical insider transactions for Strayer Education go as follows:

  • 4-Week # shares sold: 2,600
  • 12-Week # shares sold: 2,600
  • 24-Week # shares bought: 4,876
  • 24-Week # shares sold: 2,600

The average volume for Strayer Education has been 124,700 shares per day over the past 30 days. Strayer Education has a market cap of $860.1 million and is part of the services sector and diversified services industry. Shares are up 121.15% year-to-date as of the close of trading on Monday.

Strayer Education, Inc., through its subsidiary, Strayer University, provides post-secondary education services for working adults. The company has a P/E ratio of 10.2. Currently, there are 2 analysts who rate Strayer Education a buy, 2 analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on STRA - FREE

TheStreet Quant Ratings rates Strayer Education as a hold. The company's strengths can be seen in multiple areas, such as its expanding profit margins, growth in earnings per share and notable return on equity. However, as a counter to these strengths, we also find weaknesses including generally higher debt management risk and weak operating cash flow. Get the full Strayer Education Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Magellan Midstream Partners L.P (MMP) - FREE Research Report

Riley Brett C, who is Senior Vice President at Magellan Midstream Partners L.P, sold 20,000 shares at $85.91 on Nov. 17, 2014. Following this transaction, the Senior Vice President owned 55,958 shares meaning that the stake was reduced by 26.33% with the 20,000-share transaction.

The shares most recently traded at $87.50, up $1.59, or 1.82% since the insider transaction. Historical insider transactions for Magellan Midstream Partners L.P go as follows:

  • 4-Week # shares bought: 500
  • 4-Week # shares sold: 1,800
  • 12-Week # shares bought: 500
  • 12-Week # shares sold: 8,800
  • 24-Week # shares bought: 500
  • 24-Week # shares sold: 28,800

The average volume for Magellan Midstream Partners L.P has been 761,200 shares per day over the past 30 days. Magellan Midstream Partners L.P has a market cap of $19.6 billion and is part of the basic materials sector and energy industry. Shares are up 37.98% year-to-date as of the close of trading on Monday.

Magellan Midstream Partners, L.P. is engaged in the transportation, storage, and distribution of refined petroleum products and crude oil in the United States. It operates in three segments: Refined Products, Crude Oil, and Marine Storage. The stock currently has a dividend yield of 3.1%. The company has a P/E ratio of 25.3. Currently, there are 8 analysts who rate Magellan Midstream Partners L.P a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MMP - FREE

TheStreet Quant Ratings rates Magellan Midstream Partners L.P as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, notable return on equity, expanding profit margins, good cash flow from operations and solid stock price performance. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Magellan Midstream Partners L.P Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Core Laboratories (CLB) - FREE Research Report

Van Geuns Lucia, who is Director at Core Laboratories, bought 95 shares at $143.98 on Nov. 17, 2014. Following this transaction, the Director owned 95 shares meaning that the stake was boosted by 100% with the 95-share transaction.

The shares most recently traded at $138.74, down $5.24, or 3.78% since the insider transaction. Historical insider transactions for Core Laboratories go as follows:

  • 4-Week # shares bought: 500
  • 4-Week # shares sold: 2,000
  • 12-Week # shares bought: 500
  • 12-Week # shares sold: 2,000
  • 24-Week # shares bought: 7,700
  • 24-Week # shares sold: 2,000

The average volume for Core Laboratories has been 499,800 shares per day over the past 30 days. Core Laboratories has a market cap of $6.1 billion and is part of the basic materials sector and energy industry. Shares are down 27.71% year-to-date as of the close of trading on Monday.

Core Laboratories N.V. provides reservoir description, production enhancement, and reservoir management services to the oil and gas industry in the Netherlands and internationally. The company operates in three segments: Reservoir Description, Production Enhancement, and Reservoir Management. The stock currently has a dividend yield of 1.44%. The company has a P/E ratio of 24.4. Currently, there are 3 analysts who rate Core Laboratories a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CLB - FREE

TheStreet Quant Ratings rates Core Laboratories as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, expanding profit margins, growth in earnings per share and increase in net income. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Core Laboratories Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Dow Falls Sharply as Apple's Slump Offsets Gains in General Electric

Dow Falls Sharply as Apple's Slump Offsets Gains in General Electric

Could Spotify Be Next on Amazon's Wish List?

Could Spotify Be Next on Amazon's Wish List?

Sprint, T-Mobile Might Have to Do More Than Make Promises to Get Deal Approved

Sprint, T-Mobile Might Have to Do More Than Make Promises to Get Deal Approved

Skechers Slumps the Most in Two Years After Soft Guidance Overshadows Solid Q1

Skechers Slumps the Most in Two Years After Soft Guidance Overshadows Solid Q1

Video: This Is One Way Millennials Are Destroying Their Financial Future

Video: This Is One Way Millennials Are Destroying Their Financial Future